10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Non-Small Cell Lung Cancer
14 articles
(Page 2)
Durvalumab Boosts Survival in Early-Stage Lung Cancer
Study finds perioperative durvalumab plus chemotherapy improves outcomes in resectable NSCLC
Blood Test Predicts Immunotherapy Response in Lung Cancer Patients
Study shows ctDNA blood test can predict immunotherapy response in advanced lung cancer patients